Company / Operating Income per Share
Neurocrine Biosciences Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$6.23
FY2025
5-year range
$1.10 / $6.23
FY2021-FY2025
Trend
+7.8%
vs FY2024
Sector context
#11 of 199
Health Care
What the data says
Among 199 Health Care companies, Neurocrine Biosciences is in the top 6% for operating income per share. Operating Income per Share has fluctuated over the past 10 years, ranging from $-1.71 in FY2016 to $6.23 in FY2025.
Based on SEC 10-K filings.
6.23 in FY2025 with a 5-year CAGR of +28.7%. Top quartile in the Health Care sector.
Improved from $2.60 to $6.23 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- +33.4%
- 5-Year CAGR
- +28.7%
- 10-Year CAGR
- -
Sector benchmark
+286.7% above sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 7.8% year-over-year.
- Ranks #11 out of 199 companies in the Health Care sector.
- Lowest operating income per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.23 | +7.8% |
| FY2024 | $5.78 | +122.3% |
| FY2023 | $2.60 | -0.9% |
| FY2022 | $2.62 | +139.3% |
| FY2021 | $1.10 | -37.9% |
| FY2020 | $1.77 | +121.8% |
| FY2019 | $0.80 | +92.1% |
| FY2018 | $0.41 | +127.4% |
| FY2017 | -$1.51 | +11.5% |
| FY2016 | -$1.71 | -38.7% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026